
### [NCIT:C40026](http://purl.obolibrary.org/obo/NCIT_C40026)
**Label:** Malignant Ovarian Epithelial Tumor

**Subclasses:** [NCIT:C5228](http://purl.obolibrary.org/obo/NCIT_C5228) (Ovarian Cystadenocarcinoma), [NCIT:C67092](http://purl.obolibrary.org/obo/NCIT_C67092) (Ovarian Serous Adenocarcinofibroma), [NCIT:C7700](http://purl.obolibrary.org/obo/NCIT_C7700) (Ovarian Adenocarcinoma), [NCIT:C105556](http://purl.obolibrary.org/obo/NCIT_C105556) (Low Grade Ovarian Serous Adenocarcinoma), [NCIT:C105555](http://purl.obolibrary.org/obo/NCIT_C105555) (High Grade Ovarian Serous Adenocarcinoma), [NCIT:C5243](http://purl.obolibrary.org/obo/NCIT_C5243) (Ovarian Mucinous Adenocarcinoma), [NCIT:C6256](http://purl.obolibrary.org/obo/NCIT_C6256) (Ovarian Serous Surface Papillary Adenocarcinoma), [NCIT:C4270](http://purl.obolibrary.org/obo/NCIT_C4270) (Malignant Ovarian Brenner Tumor), [NCIT:C7980](http://purl.obolibrary.org/obo/NCIT_C7980) (Ovarian Clear Cell Cystadenocarcinoma), [NCIT:C5240](http://purl.obolibrary.org/obo/NCIT_C5240) (Ovarian Transitional Cell Carcinoma), [NCIT:C40025](http://purl.obolibrary.org/obo/NCIT_C40025) (Malignant Ovarian Serous Tumor), [NCIT:C40089](http://purl.obolibrary.org/obo/NCIT_C40089) (Malignant Ovarian Transitional Cell Tumor), [NCIT:C9192](http://purl.obolibrary.org/obo/NCIT_C9192) (Ovarian Carcinosarcoma), [NCIT:C36102](http://purl.obolibrary.org/obo/NCIT_C36102) (Hereditary Ovarian Carcinoma), [NCIT:C40440](http://purl.obolibrary.org/obo/NCIT_C40440) (Ovarian Small Cell Carcinoma, Pulmonary Type), [NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation), [NCIT:C7979](http://purl.obolibrary.org/obo/NCIT_C7979) (Ovarian Endometrioid Adenocarcinoma), [NCIT:C7978](http://purl.obolibrary.org/obo/NCIT_C7978) (Ovarian Serous Cystadenocarcinoma), [NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma), [NCIT:C5238](http://purl.obolibrary.org/obo/NCIT_C5238) (Ovarian Large Cell Neuroendocrine Carcinoma), [NCIT:C7833](http://purl.obolibrary.org/obo/NCIT_C7833) (Recurrent Ovarian Carcinoma), [NCIT:C7550](http://purl.obolibrary.org/obo/NCIT_C7550) (Ovarian Serous Adenocarcinoma), [NCIT:C40078](http://purl.obolibrary.org/obo/NCIT_C40078) (Ovarian Clear Cell Adenocarcinoma), [NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma), [NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma), [NCIT:C40033](http://purl.obolibrary.org/obo/NCIT_C40033) (Malignant Ovarian Mucinous Tumor), [NCIT:C40077](http://purl.obolibrary.org/obo/NCIT_C40077) (Malignant Ovarian Clear Cell Tumor), [NCIT:C40051](http://purl.obolibrary.org/obo/NCIT_C40051) (Malignant Ovarian Endometrioid Tumor), [NCIT:C27390](http://purl.obolibrary.org/obo/NCIT_C27390) (Ovarian Small Cell Carcinoma), [NCIT:C4908](http://purl.obolibrary.org/obo/NCIT_C4908) (Ovarian Carcinoma), [NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma), [NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma), [NCIT:C4509](http://purl.obolibrary.org/obo/NCIT_C4509) (Undifferentiated Ovarian Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 55.75%
- [NCIT:C25785](http://purl.obolibrary.org/obo/NCIT_C25785) (KRAS Gene) 51.00%
- [NCIT:C20987](http://purl.obolibrary.org/obo/NCIT_C20987) (CTNNB1 Gene) 51.00%
- [NCIT:C18363](http://purl.obolibrary.org/obo/NCIT_C18363) (BRAF Gene) 51.00%
- [NCIT:C18256](http://purl.obolibrary.org/obo/NCIT_C18256) (PTEN Gene) 51.00%
- [NCIT:C18120](http://purl.obolibrary.org/obo/NCIT_C18120) (BRCA2 Gene) 51.00%
- [NCIT:C17965](http://purl.obolibrary.org/obo/NCIT_C17965) (BRCA1 Gene) 51.00%
- [NCIT:C17359](http://purl.obolibrary.org/obo/NCIT_C17359) (TP53 Gene) 51.00%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C36493](http://purl.obolibrary.org/obo/NCIT_C36493) (High-Frequency Microsatellite Instability))) 51.00%
- [NCIT:C48189](http://purl.obolibrary.org/obo/NCIT_C48189) (Genomic Instability) 36.36%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) 36.36%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C40258](http://purl.obolibrary.org/obo/NCIT_C40258) (Vaginal Tubulovillous Adenoma))) 36.36%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C40257](http://purl.obolibrary.org/obo/NCIT_C40257) (Vaginal Tubular Adenoma))) 36.36%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 36.36%
- [NCIT:C36318](http://purl.obolibrary.org/obo/NCIT_C36318) (Microsatellite Instability) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 36.36%


